Technology News and Research

RSS

Tel Aviv University researchers discover link between sharp vision and the brain's processing speed

Middle-aged adults who suddenly need reading glasses, patients with traumatic brain injuries, and people with visual disorders such as "lazy eye" may have one thing in common --"visual crowding," an inability to recognize individual items surrounded by multiple objects. Visual crowding makes it impossible to read, as single letters within words are rendered illegible. And basic cognitive functions such as facial recognition can also be significantly hampered. Scientists and clinicians currently attribute crowding to a disorder in peripheral vision.

5 Mar 2014

Alzheimer's drug pioneer to be awarded Israel Prize for Medicine

Israel's Minister of Education Shai Piron has announced that the Israel Prize for Medicine will be awarded to the Hebrew University of Jerusalem's Prof. Marta Weinstock-Rosin. A professor emeritus at the Hebrew University's School of Pharmacy-Institute for Drug Research in the Faculty of Medicine, Weinstock-Rosin is best known for developing Exelon, a blockbuster drug for the treatment of confusion and dementia related to Alzheimer's and Parkinson's diseases.

5 Mar 2014

Study: Facebook use may increase risk of eating disorders, low self-esteem

Facebook has become a global phenomenon and an active space for social comparison. With the increase in technology use, there is a positive correlation with decreased body image in young women.

5 Mar 2014

The Gordon & Llura Gund Foundations donates $3M to support Autism Speaks' Aut10K program

Autism Speaks, the world's leading autism science and advocacy organization, today announced that The Gordon & Llura Gund Foundation and The Gordon & Llura Gund 93 Foundation have donated a combined $3 million to support Autism Speaks' Autism Ten Thousand Genomes (Aut10K) program to sequence the world's largest collection of whole genomes of individuals with autism spectrum disorder (ASD) and their family members.

5 Mar 2014

Bruker opens new preclinical imaging center of excellence for the Americas

Bruker (NASDAQ: BRKR) today announced the official opening of a new Preclinical Imaging Center of Excellence for the Americas in Billerica, Massachusetts. The facility offers advanced development, demonstration and support facilities for Bruker’s industry-leading portfolio of preclinical imaging instrumentation and multimodal platforms.

4 Mar 2014

New minispec sample automation system for TD-NMR applications delivers increased productivity and efficiency

At Pittcon 2014 Bruker announced a new sample automation system for the minispec mq and mq-one series, a new easy to use and cost-effective system that brings sample automation to routine Time-Domain (TD)-NMR applications. Its fast sample exchange of 10mm OD sample tubes delivers new levels of maximum throughput and thanks to automated and precise tempering times measurement reliability is improved, significantly boosting productivity of the minispec series.

4 Mar 2014

Bruker announces successful installation of World’s First compact 900 MHz actively refrigerated magnet for NMR spectroscopy at UCSD

Bruker today announced the successful installation of an Ascend™ Aeon 900 magnet, the world’s first compact, single-story NMR magnet with active refrigeration at the University of California, San Diego (UCSD) in La Jolla, CA.

4 Mar 2014

Beckman Coulter Life Sciences announces agreement with Wyatt Technology Corporation

Beckman Coulter Life Sciences today announced an agreement with Wyatt Technology Corporation enabling collaboration on products, applications and technical development. The partnership brings together Wyatt’s expertise in protein characterization, light scattering and biophysics with Beckman Coulter’s expertise in particle counting, particle characterization and cell viability measurement.

4 Mar 2014

Neos Therapeutics completes private financing round, raises $15.5M

Neos Therapeutics, Inc. ("Neos" or "the Company"), a highly differentiated oral drug delivery company with an exciting portfolio of proprietary technologies and a late-stage pipeline of innovative controlled release (CR) products for ADHD, announced today that it has completed an oversubscribed round of private financing, raising a total of $15.5 million.

4 Mar 2014

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

Ziehm Imaging is announced to be the winner in the category "Best Company for Innovation & Leadership" at this year's IAIR GLOBAL AWARDS. More than 500 attendees were present at the award dinner held at the Sheraton Tower in Hong Kong last Friday.

4 Mar 2014

FDA clears First Response Gold Digital Pregnancy Test

Church & Dwight Co., Inc. announced today that the U.S. Food and Drug Administration has cleared the First Response Gold Digital Pregnancy Test to determine if a woman is pregnant up to six (6) days before her missed period and with over 99% accuracy from the day of her expected period – a significant step in pregnancy test innovation.

4 Mar 2014

NC-stat DPNCheck is a fast, accurate point-of-care test for diabetic peripheral neuropathy

NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.

4 Mar 2014

Procellera technology enhances cell migration in in-vitro laboratory testing

Procellera – the world's first wireless microcurrent generating dressing that produces electrical fields through its matrix of microcell batteries – was found to significantly enhance cell migration in in-vitro laboratory testing, according to groundbreaking research led by The Ohio State University Wexner Medical Center Professor Chandan K. Sen. Professor Sen is also the Director of the Comprehensive Wound Center at Ohio State.

4 Mar 2014

New uses of imaging technologies could help scientists uncover brain's mysteries

Combining two imagine technologies, such as MRI for structure and MEG for activity, could provide a new understanding of our how our brain works.

4 Mar 2014

Bruker launches new, improved customer-driven products at Pittcon 2014

At Pittcon 2014, Bruker today announced new product introductions and enhancements for improved performance and customer experience in research, industrial and applied markets.

4 Mar 2014

Researchers identify eight neural subnetworks in mammalian cerebral cortex

The mammalian cerebral cortex, long thought to be a dense single interrelated tangle of neural networks, actually has a "logical" underlying organizational principle, reveals a study appearing Feb. 27 in the journal Cell.

4 Mar 2014

Invuity secures $36 million round of financing led by HC Royalty

Invuity, Inc., a developer of advanced medical devices to dramatically improve access and visualization in minimally invasive and minimal access surgeries, announced today that it has secured $36 million in a Series E financing led by HealthCare Royalty Partners, along with existing investors Valence Life Sciences, InterWest Partners, Kleiner Perkins Caufield and Byers, and a number of other qualified investors.

4 Mar 2014

New research project explores link between pitch count and throwing arm injuries

The correlation between pitch count and throwing arm injuries has been a hot-button issue in baseball for years and now is the focus of a pioneering study by the Mercyhurst University Department of Sports Medicine, UPMC Hamot and Shriners Hospitals for Children - Erie.

4 Mar 2014

Oxford Gene Technology announces acquisition of Cytocell

Oxford Gene Technology, a provider of innovative genetics research solutions, today announced the acquisition of Cambridge-based Cytocell Limited, a leading provider of DNA technology for the detection of gene rearrangements related to inherited genetic disease and cancer.

From Oxford Gene Technology 4 Mar 2014

LFB SA initiates Phase 3 program for human Factor VIIa in patients with congenital hemophilia

LFB SA, through its rEVO Biologics subsidiary, announced today initiation of the global Phase 3 program for LR769, a novel recombinant form of human Factor VIIa, in patients with congenital hemophilia A or B with inhibitors.

4 Mar 2014

Technology News and Research

Tel Aviv University researchers discover link between sharp vision and the brain's processing speed

Alzheimer's drug pioneer to be awarded Israel Prize for Medicine

Study: Facebook use may increase risk of eating disorders, low self-esteem

The Gordon & Llura Gund Foundations donates $3M to support Autism Speaks' Aut10K program

Bruker opens new preclinical imaging center of excellence for the Americas

New minispec sample automation system for TD-NMR applications delivers increased productivity and efficiency

Bruker announces successful installation of World’s First compact 900 MHz actively refrigerated magnet for NMR spectroscopy at UCSD

Beckman Coulter Life Sciences announces agreement with Wyatt Technology Corporation

Neos Therapeutics completes private financing round, raises $15.5M

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

FDA clears First Response Gold Digital Pregnancy Test

NC-stat DPNCheck is a fast, accurate point-of-care test for diabetic peripheral neuropathy

Procellera technology enhances cell migration in in-vitro laboratory testing

New uses of imaging technologies could help scientists uncover brain's mysteries

Bruker launches new, improved customer-driven products at Pittcon 2014

Researchers identify eight neural subnetworks in mammalian cerebral cortex

Invuity secures $36 million round of financing led by HC Royalty

New research project explores link between pitch count and throwing arm injuries

Oxford Gene Technology announces acquisition of Cytocell

LFB SA initiates Phase 3 program for human Factor VIIa in patients with congenital hemophilia

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News